A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

The post Researchers Working On mRNA Cancer Treatments May Have Stumbled On A Universal Treatment For All Cancer Types first ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a ...

The Department of Health and Human Services (HHS) announced this week it is beginning a "coordinated wind-down" of federally funded mRNA vaccine development. This includes terminating awards and ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped in the afternoon session after the company ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

Moderna Inc. (NASDAQ: MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...